SciELO - Scientific Electronic Library Online

vol.40 número4Active Brazilian crack cocaine users: nutritional, anthropometric, and drug use profilesHypericum perforatum chronic treatment affects cognitive parameters and brain neurotrophic factor levels índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




Links relacionados


Brazilian Journal of Psychiatry

versão impressa ISSN 1516-4446versão On-line ISSN 1809-452X


DA SILVA, Sally K. et al. Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder. Rev. Bras. Psiquiatr. [online]. 2018, vol.40, n.4, pp.361-366.  Epub 11-Jun-2018. ISSN 1809-452X.


To correlate neurotrophic factors – brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and beta-nerve growth factor (beta-NGF) – and severity of depressive symptoms in patients diagnosed with major depressive disorder (MDD) undergoing cognitive-behavioral therapy (CBT).


In this quasi-experimental study, participants were selected by convenience and received 16 sessions of CBT. The outcomes of interest were severity of depressive symptoms and changes in neurotrophic factor levels after CBT. The differences between variables before and after treatment (deltas) were analyzed.


Patients had significant changes in symptom severity after treatment. No significant associations were found between Beck Depression Inventory II (BDI-II) scores and any independent variable. No correlations were observed between BDNF or GDNF levels and BDI scores before or after treatment, although there was a trend toward significant differences in beta-NGF levels.


BDNF, beta-NGF, and GDNF were not influenced by the effects of CBT on depressive symptoms.

Palavras-chave : Blood; neurotrophic factor; major depressive disorder; cognitive-behavioral therapy.

        · texto em Inglês     · Inglês ( pdf )